Treating obesity using glucagon-like peptide-1-directed N-methyl-D-aspartate receptor inhibition Post author: Post published:May 20, 2024 Post category:uncategorized Bimodal drug that successfully cures obesity, hyperglycemia, and dyslipidemia in mouse models. You Might Also Like AHA scientific statement: Advances and challenges in AI applications for cardiovascular medicine February 28, 2024 Study finds lack of consensus on how to treat chronic non-cancer pain February 22, 2025 Study reveals how tiny tweaks to actin shape our cells December 24, 2023
AHA scientific statement: Advances and challenges in AI applications for cardiovascular medicine February 28, 2024